How many insider trades does FilingIQ track for SEER?

FilingIQ tracks 175 Form 4 insider transactions for SEER (Seer, Inc.), covering filings from Dec 8, 2020 onwards. 7 of those are dated within the last 90 days.

Are SEER insiders net buyers or net sellers?

Across the full Form 4 history for SEER, 11 transactions (6%) were open-market purchases and 67 (38%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SEER insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is SEER in?

Seer, Inc. (SEER) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $112.22M.

SEER insider trading

Healthcare

Seer, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

175

Last 90 days

Buys / sells

6% / 38%

Market cap

$112.22M

About Seer, Inc.

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Company website: seer.bio

SEER insider activity at a glance

FilingIQ tracks 175 insider transactions for SEER in filings since Dec 8, 2020. The most recent transaction is dated Aug 18, 2026.

Across the full history, 11 open-market purchases and 67 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SEER insider trades is 58.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SEER trades on FilingIQ Raw filings on SEC EDGAR

Latest SEER Form 4 filings

Horn David R. PRESIDENT & CFO

Roelofs Nicolas H PHD

Horn David R. PRESIDENT & CFO

S May 21, 2026

Bazarko Anthony R. Chief Commercial Officer

A May 11, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

13F funds holding SEER

SOFTBANK GROUP CORP.

$8.52M · 0.0% of AUM

Frequently asked

How many insider trades does FilingIQ track for SEER?: FilingIQ tracks 175 Form 4 insider transactions for SEER (Seer, Inc.), covering filings from Dec 8, 2020 onwards. 7 of those are dated within the last 90 days.
Are SEER insiders net buyers or net sellers?: Across the full Form 4 history for SEER, 11 transactions (6%) were open-market purchases and 67 (38%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SEER insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is SEER in?: Seer, Inc. (SEER) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $112.22M.

Methodology & sources

Every SEER insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.